COMMUNIQUÉ DE PRESSE publié le 18/01/2024 à 13:00, il y a 2 années 5 mois Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
COMMUNIQUÉ DE PRESSE publié le 16/01/2024 à 13:00, il y a 2 années 5 mois Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
COMMUNIQUÉ DE PRESSE publié le 15/11/2023 à 13:00, il y a 2 années 7 mois Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
COMMUNIQUÉ DE PRESSE publié le 15/06/2023 à 13:00, il y a 3 années OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
COMMUNIQUÉ DE PRESSE publié le 09/05/2023 à 13:00, il y a 3 années 1 mois Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
COMMUNIQUÉ DE PRESSE publié le 04/05/2023 à 13:00, il y a 3 années 1 mois Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
COMMUNIQUÉ DE PRESSE publié le 03/05/2023 à 15:05, il y a 3 années 1 mois Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
COMMUNIQUÉ DE PRESSE publié le 01/05/2023 à 13:00, il y a 3 années 1 mois Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
COMMUNIQUÉ DE PRESSE publié le 30/03/2023 à 13:00, il y a 3 années 2 mois Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
COMMUNIQUÉ DE PRESSE publié le 29/03/2023 à 17:45, il y a 3 années 2 mois Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Publié le 26/06/2026 à 17:45, il y a 13 heures 51 minutes Descriptif du programme de rachat d'actions
Publié le 27/06/2026 à 01:40, il y a 5 heures 56 minutes Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Publié le 27/06/2026 à 00:00, il y a 7 heures 36 minutes Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Publié le 26/06/2026 à 23:00, il y a 8 heures 36 minutes Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 8 heures 46 minutes Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 26/06/2026 à 22:15, il y a 9 heures 21 minutes Revive Therapeutics Announces Proposed Private Placement
Publié le 27/06/2026 à 00:05, il y a 7 heures 30 minutes EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Publié le 27/06/2026 à 00:04, il y a 7 heures 31 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 8 heures Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 8 heures EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 8 heures 8 minutes EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE